These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24220561)

  • 1. Is antiviral prophylaxis necessary to prevent hepatitis B virus (HBV) reactivation in patients with HBV-resolved infection receiving rituximab-containing chemotherapy?
    Kusumoto S; Tanaka Y; Mizokami M; Ueda R
    J Clin Oncol; 2013 Dec; 31(35):4480. PubMed ID: 24220561
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B.
    Huang YH; Hsiao LT; Hong YC; Chiou TJ; Yu YB; Gau JP; Liu CY; Yang MH; Tzeng CH; Lee PC; Lin HC; Lee SD
    J Clin Oncol; 2013 Aug; 31(22):2765-72. PubMed ID: 23775967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis B reactivation and timing for prophylaxis.
    Tuna N; Karabay O
    World J Gastroenterol; 2015 Feb; 21(7):2263-4. PubMed ID: 25717269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study Group.
    Kim SJ; Hsu C; Song YQ; Tay K; Hong XN; Cao J; Kim JS; Eom HS; Lee JH; Zhu J; Chang KM; Reksodiputro AH; Tan D; Goh YT; Lee J; Intragumtornchai T; Chng WJ; Cheng AL; Lim ST; Suh C; Kwong YL; Kim WS
    Eur J Cancer; 2013 Nov; 49(16):3486-96. PubMed ID: 23910494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis B surface antigen seroconversion after HBV reactivation in non-Hodgkin's lymphoma.
    Liu WP; Zheng W; Song YQ; Ping LY; Wang GQ; Zhu J
    World J Gastroenterol; 2014 May; 20(17):5165-70. PubMed ID: 24803836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of entecavir in hepatitis B virus reactivation of a patient with non-Hodgkin's lymphoma.
    Gozdas HT; Arpaci E
    World J Gastroenterol; 2015 Sep; 21(35):10251-2. PubMed ID: 26401092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B virus reactivation in patients receiving chemotherapy for cancer treatment: role of Lamivudine prophylaxis.
    Coiffier B
    Cancer Invest; 2006; 24(5):548-52. PubMed ID: 16939967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
    Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
    Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High titers of anti-HBs prevent rituximab-related viral reactivation in resolved hepatitis B patient with non-Hodgkin's lymphoma.
    Cho Y; Yu SJ; Cho EJ; Lee JH; Kim TM; Heo DS; Kim YJ; Yoon JH
    J Med Virol; 2016 Jun; 88(6):1010-7. PubMed ID: 26531242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reply to S. Kusumoto et al.
    Huang YH; Lin HC; Lee SD
    J Clin Oncol; 2013 Dec; 31(35):4481. PubMed ID: 24220562
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis B reactivation induced by Rituximab maintenance therapy for lymphoma.
    Cho CH; Hwang WL; Cheng SB; Lee TY; Teng CL
    Ann Hematol; 2011 Jan; 90(1):111-2. PubMed ID: 20407894
    [No Abstract]   [Full Text] [Related]  

  • 12. Very late onset hepatitis-B virus reactivation following rituximab despite lamivudine prophylaxis: the need for continued vigilance.
    Chew E; Thursky K; Seymour JF
    Leuk Lymphoma; 2014 Apr; 55(4):938-9. PubMed ID: 23772645
    [No Abstract]   [Full Text] [Related]  

  • 13. Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab.
    Buensalido JA; Chandrasekar PH
    Expert Rev Anti Infect Ther; 2014 Feb; 12(2):151-4. PubMed ID: 24341369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal reactivation of occult hepatitis B virus infection after rituximab and chemotherapy in lymphoma: necessity of antiviral prophylaxis.
    Zhang B; Wang J; Xu W; Wang L; Ni W
    Onkologie; 2010; 33(10):537-9. PubMed ID: 20926902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivation of resolved hepatitis B during rituximab therapy for rheumatoid arthritis.
    Ghrénassia E; Mékinian A; Rouaghe S; Ganne N; Fain O
    Joint Bone Spine; 2012 Jan; 79(1):100-1. PubMed ID: 21944979
    [No Abstract]   [Full Text] [Related]  

  • 16. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.
    Uchiyama M; Tamai Y; Ikeda T
    Int J Infect Dis; 2010 Mar; 14(3):e265-6. PubMed ID: 19665406
    [No Abstract]   [Full Text] [Related]  

  • 17. Adherence to hepatitis B screening and prophylactic lamivudine for prevention of rituximab-associated hepatitis B reactivation.
    Liu CY; Chandrasekar PH; Masood A; Schiffer CA
    J Oncol Pharm Pract; 2013 Mar; 19(1):18-23. PubMed ID: 22635416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial.
    Huang H; Li X; Zhu J; Ye S; Zhang H; Wang W; Wu X; Peng J; Xu B; Lin Y; Cao Y; Li H; Lin S; Liu Q; Lin T
    JAMA; 2014 Dec; 312(23):2521-30. PubMed ID: 25514302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
    Viganò M; Mangia G; Lampertico P
    Expert Opin Biol Ther; 2014 Jul; 14(7):1019-31. PubMed ID: 24909454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivation of Occult Hepatitis B Virus Infection 27 Months after the End of Chemotherapy Including Rituximab for Malignant Lymphoma.
    Muraishi J; Shibata M; Honma Y; Hiura M; Abe S; Harada M
    Intern Med; 2017; 56(15):1967-1971. PubMed ID: 28768965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.